Glenmark Pharma Received Approval For Tacrolimus Capsules Thus Expand Its Presence In The Global Tacrolimus Market
Growing organ transplant procedures around the globe are driving the growth of the Tacrolimus market. It is mostly used as an immunosuppressant after organ transplant procedures application. This is expected to increase organ transplant procedures. Moreover, improvement in the transplantation procedure such as feasibility and a better understanding of immunology is again expected to foster the growth of the market. For instance, in February 2021, India-based generics makers Biocon and Lupin have both launched generic tacrolimus capsules in the US. It had launched tacrolimus capsules at doses of 0.5 mg, 1 mg, and 5 mg. 1. In June 2020, Sandoz announced the launch of once-daily generic tacrolimus capsules known as Dailiport® in Germany, the UK, Netherlands, Finland, Sweden, Estonia, Latvia, Slovakia, and as Conferoport® in Italy and Spain 2. In March 2019, Astellas announced the launch of PROGRAF® Granules (ta...